Please assess the completion status of the following clinical trial:

Trial Title: Simvastatin and Diastolic Dysfunction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* men or postmenopausal women aged between 40 and 65 years old~* normal fasting blood glucose (\<100 mg/dL) and glucose tolerance test (\<140 mg/dL)~* waist circumference \< 102 cm (men) or \< 88cm (women)~* triglycerides \<150 mg/dL, LDL cholesterol ≤ 160 mg/dl~* creatinine \<1.2 mg/dL, sinus rhythm~* the presence of grade 1 or 2 of DD with an ejection fraction of left ventricle \> 55%~* absence of myocardial ischemia during dobutamine stress echocardiography~Exclusion Criteria:~* thyroid dysfunction~* acute or chronic liver disease~* regular use of 3 or more antihypertensive drugs~* secondary hypertension~* symptoms or history of atherosclerotic disease~* valvular dysfunction~* LVH 14 and use of statins in the last 6 months

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo
- Simvastatin (Type: EXPERIMENTAL): Simvastatin 80 mg/day

Based on this trial design, predict the completion outcome and termination type (if applicable).